nodes	percent_of_prediction	percent_of_DWPC	metapath
Lumiracoxib—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.178	0.195	CbGbCtD
Lumiracoxib—PTGS2—Etoposide—uterine cancer	0.155	0.17	CbGbCtD
Lumiracoxib—CYP2C19—Progesterone—uterine cancer	0.141	0.155	CbGbCtD
Lumiracoxib—PTGS1—Etoposide—uterine cancer	0.131	0.144	CbGbCtD
Lumiracoxib—CYP1A2—Progesterone—uterine cancer	0.131	0.143	CbGbCtD
Lumiracoxib—CYP2C9—Progesterone—uterine cancer	0.118	0.129	CbGbCtD
Lumiracoxib—CYP1A2—Etoposide—uterine cancer	0.0584	0.0641	CbGbCtD
Lumiracoxib—Mefenamic acid—AKR1C1—uterine cancer	0.00662	0.33	CrCbGaD
Lumiracoxib—Meclofenamic acid—AKR1C3—uterine cancer	0.00494	0.246	CrCbGaD
Lumiracoxib—PTGS1—oviduct—uterine cancer	0.00401	0.119	CbGeAlD
Lumiracoxib—Mefenamic acid—AKR1C3—uterine cancer	0.00384	0.191	CrCbGaD
Lumiracoxib—UGT1A9—renal system—uterine cancer	0.00355	0.105	CbGeAlD
Lumiracoxib—Tolmetin—CXCL8—uterine cancer	0.00301	0.15	CrCbGaD
Lumiracoxib—PTGS1—artery—uterine cancer	0.00266	0.0787	CbGeAlD
Lumiracoxib—PTGS2—artery—uterine cancer	0.00254	0.0753	CbGeAlD
Lumiracoxib—Diclofenac—CXCL8—uterine cancer	0.00166	0.0827	CrCbGaD
Lumiracoxib—PTGS2—myometrium—uterine cancer	0.00123	0.0364	CbGeAlD
Lumiracoxib—CYP1A2—renal system—uterine cancer	0.00108	0.032	CbGeAlD
Lumiracoxib—PTGS1—epithelium—uterine cancer	0.00101	0.0299	CbGeAlD
Lumiracoxib—PTGS1—uterine cervix—uterine cancer	0.000999	0.0296	CbGeAlD
Lumiracoxib—PTGS1—smooth muscle tissue—uterine cancer	0.000971	0.0288	CbGeAlD
Lumiracoxib—PTGS2—epithelium—uterine cancer	0.000963	0.0285	CbGeAlD
Lumiracoxib—CYP2C19—vagina—uterine cancer	0.000956	0.0283	CbGeAlD
Lumiracoxib—PTGS2—uterine cervix—uterine cancer	0.000955	0.0283	CbGeAlD
Lumiracoxib—PTGS1—renal system—uterine cancer	0.000934	0.0277	CbGeAlD
Lumiracoxib—PTGS2—smooth muscle tissue—uterine cancer	0.000928	0.0275	CbGeAlD
Lumiracoxib—PTGS1—endometrium—uterine cancer	0.000903	0.0268	CbGeAlD
Lumiracoxib—PTGS2—renal system—uterine cancer	0.000893	0.0265	CbGeAlD
Lumiracoxib—PTGS1—mammalian vulva—uterine cancer	0.000874	0.0259	CbGeAlD
Lumiracoxib—PTGS2—endometrium—uterine cancer	0.000864	0.0256	CbGeAlD
Lumiracoxib—PTGS1—uterus—uterine cancer	0.000832	0.0247	CbGeAlD
Lumiracoxib—CYP2C9—female reproductive system—uterine cancer	0.00082	0.0243	CbGeAlD
Lumiracoxib—PTGS2—uterus—uterine cancer	0.000796	0.0236	CbGeAlD
Lumiracoxib—PTGS1—female reproductive system—uterine cancer	0.000748	0.0222	CbGeAlD
Lumiracoxib—PTGS2—female reproductive system—uterine cancer	0.000715	0.0212	CbGeAlD
Lumiracoxib—PTGS1—female gonad—uterine cancer	0.000681	0.0202	CbGeAlD
Lumiracoxib—PTGS1—vagina—uterine cancer	0.000677	0.0201	CbGeAlD
Lumiracoxib—PTGS2—female gonad—uterine cancer	0.000651	0.0193	CbGeAlD
Lumiracoxib—PTGS2—vagina—uterine cancer	0.000647	0.0192	CbGeAlD
Lumiracoxib—PTGS1—lymph node—uterine cancer	0.000438	0.013	CbGeAlD
Lumiracoxib—PTGS2—lymph node—uterine cancer	0.000418	0.0124	CbGeAlD
Lumiracoxib—CYP1A2—Metapathway biotransformation—AKR1B1—uterine cancer	0.00015	0.00427	CbGpPWpGaD
Lumiracoxib—PTGS1—Selenium Micronutrient Network—CCL2—uterine cancer	0.00015	0.00426	CbGpPWpGaD
Lumiracoxib—PTGS1—Biological oxidations—CYP19A1—uterine cancer	0.000149	0.00424	CbGpPWpGaD
Lumiracoxib—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—uterine cancer	0.000148	0.00421	CbGpPWpGaD
Lumiracoxib—CYP2C9—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.000148	0.0042	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	0.000143	0.00406	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metapathway biotransformation—AKR1C1—uterine cancer	0.000142	0.00402	CbGpPWpGaD
Lumiracoxib—PTGS2—Aryl Hydrocarbon Receptor—EP300—uterine cancer	0.000136	0.00386	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	0.00013	0.0037	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—STAR—uterine cancer	0.00013	0.0037	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—EZH2—uterine cancer	0.00013	0.00368	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metapathway biotransformation—AKR1C1—uterine cancer	0.000129	0.00367	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—uterine cancer	0.000129	0.00365	CbGpPWpGaD
Lumiracoxib—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—uterine cancer	0.000129	0.00365	CbGpPWpGaD
Lumiracoxib—PTGS2—Aryl Hydrocarbon Receptor—NRAS—uterine cancer	0.000127	0.00361	CbGpPWpGaD
Lumiracoxib—CYP1A2—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.000126	0.00359	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metapathway biotransformation—GPX3—uterine cancer	0.000124	0.00353	CbGpPWpGaD
Lumiracoxib—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—uterine cancer	0.000121	0.00343	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—ESR2—uterine cancer	0.00012	0.00341	CbGpPWpGaD
Lumiracoxib—PTGS2—Selenium Micronutrient Network—CCL2—uterine cancer	0.000119	0.00338	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	0.000117	0.00333	CbGpPWpGaD
Lumiracoxib—CYP2C19—Biological oxidations—CYP11A1—uterine cancer	0.000117	0.00332	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metapathway biotransformation—CYP11A1—uterine cancer	0.000115	0.00328	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metapathway biotransformation—GPX3—uterine cancer	0.000113	0.00322	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metapathway biotransformation—AKR1C1—uterine cancer	0.00011	0.00313	CbGpPWpGaD
Lumiracoxib—PTGS2—Aryl Hydrocarbon Receptor—KRAS—uterine cancer	0.000109	0.0031	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	0.000109	0.0031	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metapathway biotransformation—AKR1C3—uterine cancer	0.000109	0.0031	CbGpPWpGaD
Lumiracoxib—PTGS2—C-MYB transcription factor network—CDKN2A—uterine cancer	0.000108	0.00306	CbGpPWpGaD
Lumiracoxib—CYP2C9—Biological oxidations—CYP11A1—uterine cancer	0.000107	0.00303	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metapathway biotransformation—CYP11A1—uterine cancer	0.000105	0.00299	CbGpPWpGaD
Lumiracoxib—UGT1A9—PPARA activates gene expression—EP300—uterine cancer	0.000104	0.00297	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	0.000104	0.00295	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	0.000103	0.00294	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—STAR—uterine cancer	0.000103	0.00294	CbGpPWpGaD
Lumiracoxib—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—uterine cancer	0.000102	0.0029	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metapathway biotransformation—AKR1C3—uterine cancer	9.94e-05	0.00282	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—NDUFB11—uterine cancer	9.85e-05	0.0028	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—SRD5A2—uterine cancer	9.85e-05	0.0028	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	9.78e-05	0.00278	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metapathway biotransformation—GPX3—uterine cancer	9.69e-05	0.00275	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	9.57e-05	0.00272	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	9.57e-05	0.00272	CbGpPWpGaD
Lumiracoxib—PTGS2—C-MYB transcription factor network—CDKN1B—uterine cancer	9.55e-05	0.00271	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	9.48e-05	0.00269	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—CCL2—uterine cancer	9.43e-05	0.00268	CbGpPWpGaD
Lumiracoxib—PTGS2—Aryl Hydrocarbon Receptor—HRAS—uterine cancer	9.3e-05	0.00264	CbGpPWpGaD
Lumiracoxib—CYP1A2—Biological oxidations—CYP11A1—uterine cancer	9.12e-05	0.00259	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	9.03e-05	0.00256	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metapathway biotransformation—CYP11A1—uterine cancer	9e-05	0.00255	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—uterine cancer	8.75e-05	0.00248	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—uterine cancer	8.75e-05	0.00248	CbGpPWpGaD
Lumiracoxib—CYP2C19—Biological oxidations—CYP19A1—uterine cancer	8.61e-05	0.00245	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metapathway biotransformation—AKR1C3—uterine cancer	8.5e-05	0.00241	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metapathway biotransformation—CYP19A1—uterine cancer	8.5e-05	0.00241	CbGpPWpGaD
Lumiracoxib—PTGS2—C-MYB transcription factor network—EP300—uterine cancer	8.39e-05	0.00238	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	8.1e-05	0.0023	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—NDUFB11—uterine cancer	8.03e-05	0.00228	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—SRD5A2—uterine cancer	8.03e-05	0.00228	CbGpPWpGaD
Lumiracoxib—CYP2C9—Biological oxidations—CYP19A1—uterine cancer	7.85e-05	0.00223	CbGpPWpGaD
Lumiracoxib—PTGS2—C-MYB transcription factor network—NRAS—uterine cancer	7.85e-05	0.00223	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	7.8e-05	0.00221	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metapathway biotransformation—CYP19A1—uterine cancer	7.75e-05	0.0022	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—uterine cancer	7.69e-05	0.00218	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor—EP300—uterine cancer	7.69e-05	0.00218	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	7.59e-05	0.00216	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—STAR—uterine cancer	7.51e-05	0.00213	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	7.51e-05	0.00213	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—CXCL8—uterine cancer	7.45e-05	0.00212	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	7.36e-05	0.00209	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	7.29e-05	0.00207	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—CDKN1B—uterine cancer	7.28e-05	0.00207	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—uterine cancer	7.28e-05	0.00207	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—uterine cancer	7.19e-05	0.00204	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—AKR1B1—uterine cancer	7.12e-05	0.00202	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—STAR—uterine cancer	7.12e-05	0.00202	CbGpPWpGaD
Lumiracoxib—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—uterine cancer	7.05e-05	0.002	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	7.04e-05	0.002	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	6.85e-05	0.00194	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—STAR—uterine cancer	6.85e-05	0.00194	CbGpPWpGaD
Lumiracoxib—PTGS2—C-MYB transcription factor network—KRAS—uterine cancer	6.76e-05	0.00192	CbGpPWpGaD
Lumiracoxib—CYP1A2—Biological oxidations—CYP19A1—uterine cancer	6.71e-05	0.00191	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metapathway biotransformation—CYP19A1—uterine cancer	6.62e-05	0.00188	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—NDUFB11—uterine cancer	6.37e-05	0.00181	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—SRD5A2—uterine cancer	6.37e-05	0.00181	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	6.19e-05	0.00176	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—uterine cancer	6.19e-05	0.00176	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—AKR1B10—uterine cancer	5.92e-05	0.00168	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	5.86e-05	0.00166	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—STAR—uterine cancer	5.86e-05	0.00166	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	5.85e-05	0.00166	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—AKR1B1—uterine cancer	5.8e-05	0.00165	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—STAR—uterine cancer	5.8e-05	0.00165	CbGpPWpGaD
Lumiracoxib—PTGS2—C-MYB transcription factor network—HRAS—uterine cancer	5.74e-05	0.00163	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	5.74e-05	0.00163	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—POLD1—uterine cancer	5.59e-05	0.00159	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	5.52e-05	0.00157	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	5.35e-05	0.00152	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—uterine cancer	5.26e-05	0.00149	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—AKR1C1—uterine cancer	5.23e-05	0.00148	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	5.03e-05	0.00143	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	4.95e-05	0.00141	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—RNF43—uterine cancer	4.9e-05	0.00139	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	4.68e-05	0.00133	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—RRM2—uterine cancer	4.66e-05	0.00132	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—SRD5A2—uterine cancer	4.63e-05	0.00131	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—NDUFB11—uterine cancer	4.63e-05	0.00131	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—STAR—uterine cancer	4.61e-05	0.00131	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—AKR1B1—uterine cancer	4.61e-05	0.00131	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—TP53—uterine cancer	4.57e-05	0.0013	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	4.56e-05	0.00129	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—POLD1—uterine cancer	4.55e-05	0.00129	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	4.55e-05	0.00129	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—DCN—uterine cancer	4.52e-05	0.00128	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	4.5e-05	0.00128	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	4.35e-05	0.00123	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	4.3e-05	0.00122	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—AKR1C1—uterine cancer	4.26e-05	0.00121	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—CYP11A1—uterine cancer	4.26e-05	0.00121	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	4.25e-05	0.00121	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—SRD5A2—uterine cancer	4.22e-05	0.0012	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—NDUFB11—uterine cancer	4.22e-05	0.0012	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	4.12e-05	0.00117	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	4.1e-05	0.00116	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—AKR1C1—uterine cancer	4.04e-05	0.00115	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—AKR1C3—uterine cancer	4.02e-05	0.00114	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	3.87e-05	0.0011	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—RRM2—uterine cancer	3.8e-05	0.00108	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—DCN—uterine cancer	3.69e-05	0.00105	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—POLD1—uterine cancer	3.62e-05	0.00103	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—NDUFB11—uterine cancer	3.61e-05	0.00102	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—SRD5A2—uterine cancer	3.61e-05	0.00102	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	3.5e-05	0.000994	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	3.5e-05	0.000994	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—DCN—uterine cancer	3.49e-05	0.000992	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—CYP11A1—uterine cancer	3.47e-05	0.000986	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—AKR1C1—uterine cancer	3.38e-05	0.00096	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—STAR—uterine cancer	3.35e-05	0.00095	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—AKR1B1—uterine cancer	3.35e-05	0.00095	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	3.31e-05	0.000939	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	3.31e-05	0.000939	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—AKR1C3—uterine cancer	3.28e-05	0.000931	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	3.22e-05	0.000913	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—STK11—uterine cancer	3.13e-05	0.00089	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—CYP19A1—uterine cancer	3.13e-05	0.00089	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	3.11e-05	0.000883	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—AKR1C3—uterine cancer	3.11e-05	0.000882	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—AKR1B1—uterine cancer	3.05e-05	0.000866	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—STAR—uterine cancer	3.05e-05	0.000866	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—HMGA1—uterine cancer	3.03e-05	0.00086	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	3.02e-05	0.000856	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—RRM2—uterine cancer	3.01e-05	0.000856	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	2.94e-05	0.000835	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—DCN—uterine cancer	2.93e-05	0.000831	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2.81e-05	0.000796	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—FBXW7—uterine cancer	2.77e-05	0.000787	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—CYP11A1—uterine cancer	2.76e-05	0.000783	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	2.63e-05	0.000746	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—POLD1—uterine cancer	2.63e-05	0.000745	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—STAR—uterine cancer	2.61e-05	0.00074	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—AKR1B1—uterine cancer	2.61e-05	0.00074	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—AKR1C3—uterine cancer	2.6e-05	0.000739	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	2.58e-05	0.000732	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—STK11—uterine cancer	2.56e-05	0.000725	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—CYP19A1—uterine cancer	2.56e-05	0.000725	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—AKR1C1—uterine cancer	2.46e-05	0.000697	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	2.4e-05	0.000681	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—POLD1—uterine cancer	2.39e-05	0.00068	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—MTHFR—uterine cancer	2.36e-05	0.000669	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2.29e-05	0.000649	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—AKR1C1—uterine cancer	2.24e-05	0.000636	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—RRM2—uterine cancer	2.19e-05	0.000621	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—CDKN2B—uterine cancer	2.17e-05	0.000616	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—DCN—uterine cancer	2.13e-05	0.000603	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.08e-05	0.000589	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—POLD1—uterine cancer	2.05e-05	0.000581	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—STK11—uterine cancer	2.03e-05	0.000576	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—CYP19A1—uterine cancer	2.03e-05	0.000576	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—CYP11A1—uterine cancer	2e-05	0.000568	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—RRM2—uterine cancer	2e-05	0.000567	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—SMAD3—uterine cancer	1.98e-05	0.000563	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—DCN—uterine cancer	1.94e-05	0.00055	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—MTHFR—uterine cancer	1.92e-05	0.000545	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—AKR1C1—uterine cancer	1.91e-05	0.000543	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.9e-05	0.00054	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—AKR1C3—uterine cancer	1.89e-05	0.000537	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—FGFR2—uterine cancer	1.89e-05	0.000537	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—CYP11A1—uterine cancer	1.83e-05	0.000518	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—MTHFR—uterine cancer	1.82e-05	0.000517	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.82e-05	0.000515	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—AKR1C3—uterine cancer	1.72e-05	0.000489	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—RRM2—uterine cancer	1.71e-05	0.000484	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.69e-05	0.00048	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—DCN—uterine cancer	1.66e-05	0.00047	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—CYP11A1—uterine cancer	1.56e-05	0.000443	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—MTHFR—uterine cancer	1.52e-05	0.000433	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—AKR1C3—uterine cancer	1.47e-05	0.000418	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—CYP19A1—uterine cancer	1.47e-05	0.000418	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—STK11—uterine cancer	1.47e-05	0.000418	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.38e-05	0.000393	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—STK11—uterine cancer	1.34e-05	0.000381	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—CYP19A1—uterine cancer	1.34e-05	0.000381	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.34e-05	0.000381	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.32e-05	0.000374	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—PTEN—uterine cancer	1.31e-05	0.000372	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.26e-05	0.000358	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—EP300—uterine cancer	1.25e-05	0.000355	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.2e-05	0.000341	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—ERBB2—uterine cancer	1.19e-05	0.000337	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—STK11—uterine cancer	1.15e-05	0.000326	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—CYP19A1—uterine cancer	1.15e-05	0.000326	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—MTHFR—uterine cancer	1.11e-05	0.000314	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—CDKN1B—uterine cancer	1.1e-05	0.000312	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.08e-05	0.000306	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—PTEN—uterine cancer	1.07e-05	0.000303	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—CTNNB1—uterine cancer	1.04e-05	0.000295	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.03e-05	0.000292	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—EP300—uterine cancer	1.02e-05	0.000289	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—PTEN—uterine cancer	1.01e-05	0.000287	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—MTHFR—uterine cancer	1.01e-05	0.000287	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	9.76e-06	0.000277	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—EP300—uterine cancer	9.66e-06	0.000274	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—PIK3CA—uterine cancer	9.24e-06	0.000262	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—NRAS—uterine cancer	9.03e-06	0.000256	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	8.9e-06	0.000252	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—MTHFR—uterine cancer	8.63e-06	0.000245	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—PTEN—uterine cancer	8.48e-06	0.000241	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—EP300—uterine cancer	8.09e-06	0.00023	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—KRAS—uterine cancer	7.78e-06	0.000221	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	7.6e-06	0.000216	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—AKT1—uterine cancer	7.55e-06	0.000214	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—PIK3CA—uterine cancer	7.54e-06	0.000214	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—PIK3CA—uterine cancer	7.14e-06	0.000203	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—HRAS—uterine cancer	6.61e-06	0.000188	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—PTEN—uterine cancer	6.16e-06	0.000175	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—AKT1—uterine cancer	6.16e-06	0.000175	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—PIK3CA—uterine cancer	5.98e-06	0.00017	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—EP300—uterine cancer	5.87e-06	0.000167	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—AKT1—uterine cancer	5.84e-06	0.000166	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—PTEN—uterine cancer	5.62e-06	0.000159	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—EP300—uterine cancer	5.36e-06	0.000152	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—AKT1—uterine cancer	4.89e-06	0.000139	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—PTEN—uterine cancer	4.8e-06	0.000136	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—EP300—uterine cancer	4.58e-06	0.00013	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—PIK3CA—uterine cancer	4.34e-06	0.000123	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—PIK3CA—uterine cancer	3.96e-06	0.000112	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—AKT1—uterine cancer	3.55e-06	0.000101	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—PIK3CA—uterine cancer	3.39e-06	9.61e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—AKT1—uterine cancer	3.24e-06	9.19e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—AKT1—uterine cancer	2.77e-06	7.85e-05	CbGpPWpGaD
